These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23915846)

  • 81. [Radiotherapy for ovarian carcinoma management: Literature review].
    Yossi S; Nguyen D; Khodri M; Reure J; Cervellera M; Lamberth F; Marchand V; Mammar V; Renoult F; Louet E; Coquard R; Barbet N; Lorchel F
    Cancer Radiother; 2020 Apr; 24(2):159-165. PubMed ID: 32151544
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Palliation of recurrent carcinoma of the cervix in a district hospital.
    Larsen JV
    S Afr Med J; 2001 Mar; 91(3):182, 184. PubMed ID: 11291407
    [No Abstract]   [Full Text] [Related]  

  • 83. Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cervical Cancer.
    Hoppenot C; Littell RD; DeEulis T; Hartenbach EM
    J Palliat Med; 2021 Mar; 24(3):438-442. PubMed ID: 33513069
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Emerging therapeutic agents for cervical cancer.
    Cornelio DB; Roesler R; Schwartsmann G
    Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):196-206. PubMed ID: 19522698
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Enhanced immune checkpoint inhibitor therapy for advanced recurrent cervical cancer: the key to treatment efficacy and maintenance of quality of life.
    Kagabu M; Baba T
    EBioMedicine; 2024 Oct; 108():105386. PubMed ID: 39342805
    [No Abstract]   [Full Text] [Related]  

  • 86. Percutaneous nephrostomy in patients with advanced or recurrent cervical cancer.
    Gadducci A; Madrigali A; Facchini V; Fioretti P
    Clin Exp Obstet Gynecol; 1994; 21(2):71-3. PubMed ID: 8070118
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cemiplimab shines for recurrent cervical cancer.
    O'Rourke K
    Cancer; 2022 Jun; 128(11):2050-2051. PubMed ID: 35532190
    [No Abstract]   [Full Text] [Related]  

  • 88. Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.
    Mackay HJ; Wenzel L; Mileshkin L
    Am Soc Clin Oncol Educ Book; 2015; ():e299-309. PubMed ID: 25993189
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The malignant psoas syndrome revisited: case report, mechanisms, and current therapeutic options.
    Stevens MJ; Atkinson C; Broadbent AM
    J Palliat Med; 2010 Feb; 13(2):211-6. PubMed ID: 20053159
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tuberculosis masquerading as recurrent metastatic carcinoma of the cervix.
    Naqiyah P H Baharudin DK; Syfiq Abdullah HJ; Chong CF; Yaakub R; Chong VH
    Ann Acad Med Singap; 2008 Sep; 37(9):811-2. PubMed ID: 18989504
    [No Abstract]   [Full Text] [Related]  

  • 91. If and when? The role of chemotherapy in locally advanced carcinoma of the cervix.
    Thigpen JT
    Ann Oncol; 1998 Sep; 9(9):933-5. PubMed ID: 9818064
    [No Abstract]   [Full Text] [Related]  

  • 92. Tisotumab vedotin effective in recurrent cervical cancer.
    Sidaway P
    Nat Rev Clin Oncol; 2024 Oct; 21(10):703. PubMed ID: 39039198
    [No Abstract]   [Full Text] [Related]  

  • 93. Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.
    Crowley FJ; O'Cearbhaill RE; Collins DC
    Cancer Treat Rev; 2021 Jul; 98():102225. PubMed ID: 34082256
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Evolving standards and future directions for systemic therapies in cervical cancer.
    Ang DJM; Chan JJ
    J Gynecol Oncol; 2024 Mar; 35(2):e65. PubMed ID: 38282261
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [II. Current Topics and Perspective of Chemotherapy for Uterine Cervical Cancer].
    Kitagawa R; Nakanishi T; Fukaya T; Watanabe Y
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):126-130. PubMed ID: 28676622
    [No Abstract]   [Full Text] [Related]  

  • 96. [The significance of Volm's oncobiogram for the therapy of advanced and recurring cervical cancer (proceedings)].
    Teufel G; Doerjer O; Pfleiderer A; Weigand I
    Arch Gynakol; 1977 Jul; 224(1-4):359-60. PubMed ID: 579859
    [No Abstract]   [Full Text] [Related]  

  • 97. Principles of radiation therapy in low-resource and well-developed settings, with particular reference to cervical cancer.
    Shrivastava SK; Mahantshetty U; Narayan K
    Int J Gynaecol Obstet; 2015 Oct; 131 Suppl 2():S153-8. PubMed ID: 26433673
    [No Abstract]   [Full Text] [Related]  

  • 98. Defining the role of high-dose radiation in oligometastatic & oligorecurrent cervical cancer.
    Mangaj A; Chopra S; Nout RA
    Indian J Med Res; 2021 Aug; 154(2):303-318. PubMed ID: 35295014
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Not Available].
    Álvarez-Altamirano K; Mendoza-Hernández AN; Carcoba-Tenorio C; García-García JA; Fuchs-Tarlovsky V
    Nutr Hosp; 2016 Mar; 33(2):125. PubMed ID: 27238806
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Gynecological cancers in developing countries: the challenge of chemotherapy in low-resources setting.
    Basile S; Angioli R; Manci N; Palaia I; Plotti F; Benedetti Panici P
    Int J Gynecol Cancer; 2006; 16(4):1491-7. PubMed ID: 16884356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.